Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NeuroEM logo — Empowering cognitive health: reversing decline and promoting...

NeuroEM

Empowering cognitive health: reversing decline and promoting lasting wellness with innovations for a brighter future

Founded 2014 United States Tampa, United States 10 employees Pre-Seed

General Information

Company Name NeuroEM
Founded Year 2014
Location United States Tampa, United States
Employees 10
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with NeuroEM. To contact NeuroEM, visit neuroem.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NeuroEM compare?

A PDF of NeuroEM and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NeuroEM soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NeuroEM

NeuroEM, a United States-based startup founded in 2014, is focused on empowering cognitive health through its groundbreaking Transcranial Electromagnetic Treatment leveraging Radio Frequencies TEMT-FT technology. The company's slogan, "Empowering cognitive health: reversing decline and promoting lasting wellness with innovations for a brighter future," reflects its commitment to revolutionizing the treatment of cognitive decline. NeuroEM aims to offer safe, effective, and non-invasive solutions based on over a decade of rigorous clinical research to halt and potentially reverse cognitive deterioration. This has the potential to bring hope to millions affected by neurodegenerative diseases like Alzheimer’s, as well as those striving to maintain cognitive health throughout the aging process. NeuroEM's last investment, a Pre Seed Round investment, was made on 01 January 2015 and was received from New York Angels, signifying early support from a notable investor. As the company continues to advance its pioneering technology, it stands to potentially attract further interest and investments from the venture capital community as it seeks to make a meaningful impact in the field of cognitive health.

Business keywords: Alzheimer's disease, Transcranial electromagnetic wave treatment, FDA approval, Breakthrough Therapy designation, Clinical trials, Cognitive decline, Neuroscience, Medical treatment, Neurological disorders, Innovative therapy, Neurological research, Medical breakthrough, Neurological therapy, Brain health

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 1
New York Angels
New York Angels
01 Jan 2015

NeuroEM Alternatives & Competitors

View All Alternatives
NeuroEM vs
BioAxone Therapeutic, Inc.
BioAxone Therapeutic, Inc.

Pioneering neuroscience solutions with breakthrough therapies for neurological disorders, including...

Series B
2 employees
Biotechnology, Health Care
NeuroEM vs
NeuroGeneces
NeuroGeneces United States

Transforming cognitive performance while you sleep

Non Equity Assistance
12 employees
Consumer Electronics, Health Care
NeuroEM vs
Phagenesis Ltd
Phagenesis Ltd United Kingdom

Dysphagia therapy like no other!

Series D
44 employees
Biotechnology, Health Care
View all alternatives

FAQ About NeuroEM

Empowering cognitive health: reversing decline and promoting lasting wellness with innovations for a brighter future
NeuroEM was founded in 2014.
NeuroEM is headquartered in Tampa, United States.
NeuroEM has approximately 10 employees.
NeuroEM has completed 1 funding round. The latest funding stage is Pre-Seed.
Top alternatives and competitors to NeuroEM include BioAxone Therapeutic, Inc., NeuroGeneces, Phagenesis Ltd, Astrocyte Pharmaceuticals, Arialys Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeuroEM and BioAxone Therapeutic, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NeuroEM, https://bouncewatch.com/company/neuroem, updated 15 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes